AbbVie

Open: 165.27 Close: 164.4 Change: -0.87

12 things an AI found about AbbVie that you should know before investing.

How much time have you spent trying to decide whether investing in AbbVie? Many investors start with the dream of being free. They expect to find on the stock market an option to have time to develop their own interests and hobbies. That is, a way to escape a 9 to 5 job. However, investment is complex and investors end up spending whole days (and nights) trying to figure out which the right stock to invest is. The dream of stock investing becomes the nightmare of facing infinity amounts of information. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about AbbVie are: AbbVie, Inc, …

Concept Map

Semantic Network

Stock Summary

AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals worldwide. The company offers Humira, a therapy administered as an injection for autoimmune, intestinal Behçet's diseases, and pyoderma gangrenos.

Today's Summary

AbbVie broke ground on a $223 million expansion of its Singapore manufacturing facility. The project is expected to create more than 100 new jobs and bolster Abbvies global biologics manufacturing capacity. CVS Health said on Wednesday it will remove AbabVies blockbuster rheumatoid arthritis drug.

Today's News

AbbVie broke ground on a $223 million expansion of its Singapore manufacturing facility. The project is expected to create more than 100 new jobs and bolster Abbvies global biologics manufacturing capacity. Abb vie currently has a Zacks Rank of #3 (Hold) The Associate General Counsel, U.S. Government Policy Legal, will be responsible for identifying, leading, and executing comprehensive legal strategies to build and implement federal and state policy initiatives to support access for AbbVie products in the United States. Abbvie is always striving to find top sales talent. The Finance Lead drives the financial planning and analysis processes and requirements across businesses supported. We are looking for a Digital Transformation & Robotics Manager in Dubai. AbbVie Inc (ABBV) stock has fallen -0.47% while the S&P 500 has risen 0.3% as of 12:10 PM on Thursday, Jan 25. The Senior Scientist I will support the formulation development, manufacturing process and testing of protein biologics drug. AbbVie Inc. - Consensus buy rating and 17.5% Upside Potential. AbbVie Inc (ABBV) stock has gained 0.63% while the S&P 500 has gained.02% as of 12:46 PM on Tuesday, Jan 23. ABBV has gained 3.07% this week: buy, hold, or sell? Find out what this means to you. AbbVie faced challenges, resulting in a decline of approximately -5.97% in revenue growth as of 30 September, 2023. The companys net margin excels beyond industry benchmarks, reaching 12.77%. Return on Equity (ROE) exceeds industry averages, highlighting the companys exceptional financial performance. AbbVie Inc. stock rises monday, outperforms market - marketwatch.com. Average price target for Abbvie is $173.64. CVS Health said on Wednesday it will remove AbbVies blockbuster rheumatoid arthritis drug Humira from some of its lists of preferred drugs for reimbursement as of April 1. CVS plans to remove AbabVies Humira.

Stock Profile

"AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals worldwide. The company offers Humira, a therapy administered as an injection for autoimmune, intestinal Behçet's diseases, and pyoderma gangrenosum; Skyrizi to treat moderate to severe plaque psoriasis, psoriatic disease, and Crohn's disease; Rinvoq, a JAK inhibitor to treat rheumatoid and psoriatic arthritis, ankylosing spondylitis, atopic dermatitis, axial spondyloarthropathy, and ulcerative colitis; Imbruvica for the treatment of adult patients with blood cancers; and Venclexta/Venclyxto to treat hematological malignancies. It also provides facial injectables, plastics and regenerative medicine, body contouring, and skincare products; Vraylar for depressive disorder; Duopa and Duodopa to treat advanced Parkinson's disease; and Ubrelvy for the acute treatment of migraine with or without aura in adults; Qulipta for episodic migraine. In addition, the company offers Lumigan/Ganfort and Alphagan/Combigan for the reduction of elevated intraocular pressure(IOP) in patients with open angle glaucoma (OAG) or ocular hypertension; Restasis, a calcineurin inhibitor immunosuppressant indicated to increase tear production; and eye care products. Further, it provides Mavyret/Maviret to treat chronic hepatitis C virus (HCV) genotype 1-6 infection and HCV genotype 1 infection; Creon, a pancreatic enzyme therapy; Lupron to treat advanced prostate cancer, endometriosis and central precocious puberty, and patients with anemia caused by uterine fibroids; Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation; and Synthroid for hypothyroidism. It has collaborations with Calico Life Sciences LLC; REGENXBIO Inc.; I-Mab Biopharma; Genmab A/S; Janssen Biotech, Inc.; and Genentech, Inc. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois."

Keywords

The game is changing. There is a new strategy to evaluate AbbVie fundamental value, possible risks and most salient advantages. Investors have traditionally relied in reading large amounts of text to evaluate the fundamental value of a stock or company. However, the development of Artificial Intelligence (AI) tools is modifying the way investments are evaluated in markets. Today, machine learning, natural language processing and bigdata allow making this process automatic, reducing large amounts of text to the elements that have a higher activation in a neural network. We programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about AbbVie are: AbbVie, Inc, support, ABBV, stock, drug, manufacturing, and the most common words in the summary are: abbvie, job, stock, market, get, direction, analyst, . One of the sentences in the summary was: AbbVie broke ground on a $223 million expansion of its Singapore manufacturing facility. Other searches related to this term that the AI found were: stockmarketlive, livestock, stockmarketforbeginners, thestockmarket, stockmarkettoday, stockmarkettrading, stockmarketstocks, todaystockmarket, thestockmarket, marketnews, stockmarketnews, whatisstockmarket, usstockmarket, stockmarketopen. #abbvie #job #stock #market #get #direction #analyst.